Target Price | $71.00 |
Price | $51.36 |
Potential |
38.24%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target iRadimed Corp 2026 .
The average iRadimed Corp target price is $71.00.
This is
38.24%
register free of charge
$72.00
40.19%
register free of charge
$70.00
36.29%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend iRadimed Corp to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the iRadimed Corp stock has an average upside potential 2026 of
38.24%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 73.24 | 79.41 |
11.71% | 8.42% | |
Net Margin | 26.03% | 25.69% |
0.54% | 1.31% |
2 Analysts have issued a sales forecast iRadimed Corp 2025 . The average iRadimed Corp sales estimate is
This results in the following potential growth metrics:
2 iRadimed Corp Analysts have issued a net profit forecast 2025. The average iRadimed Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.50 | 1.61 |
11.11% | 7.33% | |
P/E | 32.00 | |
EV/Sales | 7.57 |
2 Analysts have issued a iRadimed Corp forecast for earnings per share. The average iRadimed Corp EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Roth MKM |
Locked
➜
Locked
|
Locked | Feb 14 2025 |
Analyst Rating | Date |
---|---|
Locked
Roth MKM:
Locked
➜
Locked
|
Feb 14 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.